Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Assets (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Current Assets readings, the most recent being $618.1 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 14.68% to $618.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $618.1 million, a 14.68% decrease, with the full-year FY2025 number at $618.1 million, down 14.68% from a year prior.
  • Current Assets hit $618.1 million in Q4 2025 for Tandem Diabetes Care, roughly flat from $616.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $850.0 million in Q4 2022 to a low of $614.8 million in Q2 2025.
  • Median Current Assets over the past 5 years was $750.4 million (2023), compared with a mean of $737.6 million.
  • Biggest five-year swings in Current Assets: skyrocketed 135.59% in 2021 and later decreased 18.05% in 2025.
  • Tandem Diabetes Care's Current Assets stood at $811.5 million in 2021, then grew by 4.74% to $850.0 million in 2022, then dropped by 12.0% to $748.0 million in 2023, then fell by 3.14% to $724.5 million in 2024, then fell by 14.68% to $618.1 million in 2025.
  • The last three reported values for Current Assets were $618.1 million (Q4 2025), $616.9 million (Q3 2025), and $614.8 million (Q2 2025) per Business Quant data.